Pfizer claims COVID pill cuts risk of severe COVID by 89%
The US pharmaceutical giant says its experimental drug was highly effective at cutting rates of hospitalization and death. It is now seeking speedy approval.
Full Article
Pfizer claims COVID pill cuts risk of severe COVID by 89%
Deutsche Welle
0 shares
1 views
You might like
Related news coverage
Seven things you need to know about Covid this morning as new pill cuts risk of death by 90%
Wales Online
Pfizer's experimental antiviral pill for Covid-19 cuts hospitalisations and deaths by 90%, the company says
-
Covid-19 in UAE: Over 23,000 high-risk patients treated with Sotrovimab
MENAFN.com
-
EU reviewing Pfizer's COVID antiviral pill for emergency use
SeattlePI.com
-
Pfizer allows 95 nations to make its COVID-19 pill, 53% of world's population likely to benefit
DNA
-
Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%
Indian Express
Advertisement
More coverage
Pfizer pill cuts risk of severe COVID-19 by 89%
MENAFN.com
(MENAFN - NewsBytes) American company Pfizer 's experimental antiviral pill to treat COVID-19 cuts the risk of hospitalization and..
-
Pfizer claims its antiviral pill 89% effective in high-risk COVID-19 cases - Know how it works
DNA
-
Pfizer COVID-19 pill '89 per cent effective against hospitalisation and deaths'
SBS
-
Pfizer claims its antiviral pill can cut COVID death risk by 89%
IndiaTimes
-
Antiviral pill cuts risk of severe COVID-19 by 89%: Pfizer
Zee News